Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
12.85
-0.02 (-0.16%)
Oct 28, 2026, 3:04 PM CST

SHE:300181 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
339.51680.88804.67931.981,082232.3
Trading Asset Securities
---15110.8365.52
Cash & Short-Term Investments
339.51680.88804.671,0831,093297.82
Cash Growth
-50.98%-15.38%-25.70%-0.91%266.97%-5.39%
Accounts Receivable
1,3701,139783.33532.42510.07337.33
Other Receivables
28.9118.0118.189.0224.4226.77
Receivables
1,3991,157801.52541.44534.5364.1
Inventory
567.42531.81523.75426.52318.83273.59
Prepaid Expenses
-3.970-7.87-
Other Current Assets
33.4817.2447.515.535.456.16
Total Current Assets
2,3392,3912,1772,0561,960941.67
Property, Plant & Equipment
1,4831,4271,2201,060972.41806.32
Long-Term Investments
337.67411.57254.64179.7392.36650.67
Goodwill
321.37130.32130.32130.32130.32130.32
Other Intangible Assets
270.5882.4275.0871.2763.0464.89
Long-Term Deferred Tax Assets
34.1431.7930.425.525.1415.51
Long-Term Deferred Charges
66.3550.0935.5825.4925.4225.6
Other Long-Term Assets
135.94186.7268.9178.0774.76113.55
Total Assets
4,9884,7123,9923,6273,6432,749

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
477.68425.26482.41433.85468.88296.77
Accrued Expenses
24.47127.2586.5382.2478.3262.33
Short-Term Debt
793.04660.09377.31193.06138.16178.2
Current Portion of Long-Term Debt
3.82--10.010.01-
Current Portion of Leases
-3.193.352.492.834.21
Current Income Taxes Payable
119.5169.2652.5432.6526.5916.46
Current Unearned Revenue
2.955.2614.452.2314.143.06
Other Current Liabilities
184.4548.6439.4638.282623.55
Total Current Liabilities
1,6061,3391,056794.83754.94584.58
Long-Term Debt
46.6611.6630.66-10-
Long-Term Leases
17.2917.0718.2716.6922.1324.27
Long-Term Unearned Revenue
27.3227.6526.519.919.7622.37
Long-Term Deferred Tax Liabilities
56.597541.0321.6876.24134.1
Total Liabilities
1,7541,4701,173853.09883.07765.31

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
701.39701.39701.39701.39701.39608.62
Additional Paid-In Capital
1,1511,1421,1351,1351,135340.48
Retained Earnings
1,2661,2571,041849.32676.8525.52
Treasury Stock
-81.45-111.88-203.97---
Comprehensive Income & Other
140.48191.6294.6342.66190.19369.44
Total Common Equity
3,1773,1802,7692,7292,7041,844
Minority Interest
57.8761.2550.5645.256.18139.15
Shareholders' Equity
3,2353,2412,8192,7742,7601,983
Total Liabilities & Equity
4,9884,7123,9923,6273,6432,749

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
860.81692.01429.59222.25173.13206.67
Net Cash (Debt)
-521.29-11.13375.08860.73919.7791.15
Net Cash Growth
---56.42%-6.42%909.09%-
Net Cash Per Share
-0.75-0.020.541.241.520.15
Filing Date Shares Outstanding
702.62693.22692.47701.39701.39608.62
Total Common Shares Outstanding
702.62693.22686.49701.39701.39608.62
Working Capital
733.161,0521,1211,2621,205357.1
Book Value Per Share
4.524.594.033.893.853.03
Tangible Book Value
2,5852,9672,5632,5272,5101,649
Tangible Book Value Per Share
3.684.283.733.603.582.71
Buildings
-1,2231,014962.71832.63678.11
Machinery
-580.69529.12467.55432.59412.82
Construction In Progress
-173.97161.4361.1478.0640.29